Acefylline clofibrol

This classification denotes a bronchodilator with the molecular formula C19H21ClN4O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WY672D78VW, chemically known as 7h-purine-7-acetic acid, 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-, 2-(4-chlorophenoxy)-2-methylpropyl ester but more generally known as acefylline clofibrol, which bears US NIH Compound Identifier 68898. European Medicines Agency schedules Acefylline clofibrol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05206MIG. The term ACEFYLLINE CLOFIBROL is an International Non-Proprietary Name. Most nations, for tariff and trade purposes, schedule acefylline clofibrol under HS 29395900 and SITC 54145. As of Q4 2014, ACEFYLLINE CLOFIBROL remains US FDA's Preferred Term for this commodity. Acefylline clofibrol bears US NLM identifiers UMLS ID C2699524 and NCI Concept Code C74216. SMILES: CC(C)(COC(=O)CN1CNC2C1C(=O)N(C(=O)N2C)C)OC3CCC(CC3)CL.